Metagenomi Share Price

Metagenomi Share Price

NASDAQ: MGX | Micro Cap | Healthcare
$0.56
-$0.07 (-10.36%) Last updated on 21 Nov, 2026 | 02:00 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Metagenomi Stock Performance

Open
$0.59
Prev. Close
$0.63
Circuit Range
N/A
Day Range
$0.56 - $0.59
Year Range
$0.56 - $1.87
Volume
4,713
Average Traded
$0.58

Metagenomi Share Price Today

As of 22 November 2026, Metagenomi Therapeutics, Inc.'s share price is $0.56. The stock opened at $0.59, compared to its previous close of $0.63. During today's trading session, Metagenomi Therapeutics, Inc.'s share price traded between $0.56 and $0.59, with an average price of $0.58. Over the past 52 weeks, the stock has recorded a high of $1.87 and a low of $0.56. In terms of performance, Metagenomi Therapeutics, Inc.'s share price has declined by 58.87% over the last six months and is down 68.07% on a year-on-year basis.

Metagenomi Share Price Chart

Line chart of the Metagenomi price trend over the selected period. The price fell overall, ranging from 0.56 to 0.59, ending at 0.56.
$0.56$0.59
L
Show Current Price
H

Metagenomi Stock Fundamentals & Key Indicators

Market Cap
$20.99M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.49
Revenue (TTM)
$25.21B
Return On Equity (TTM)
-101.08%
Profit Margin
-348.55%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
6.21%

Metagenomi Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$3.91$1.25-$0.26$2.18
Net Profit-$22.53-$23.06-$27.48-$21.13
Net Profit Margin-576.21%-1844.80%10569.23%-969.27%
Income ChangeN/A-2.35%-19.17%23.11%

Metagenomi Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$52.30$25.21
Net Profit-$78.06-$87.87
Net Profit Margin-149.25%-348.55%
Income ChangeN/A-12.57%

Metagenomi Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets55.5766.64
Current Assets165.54257.96
Total Assets221.1324.6
Non Current Liabilities39.5752.43
Current Liabilities22.9337.31
Total Liabilities62.5189.74
Shareholders' Equity158.6234.86

Metagenomi Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-88.89-109.07
Investing103.53-88.16
Financing-0.3684.01

About Metagenomi

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature gene editing systems. MGX-001 is its, wholly-owned development program in hemophilia A, where the company have demonstrated targeted genome editing and durable gene expression from a one-time treatment in non-human primates (NHPs) and an overall profile potentially competitive with best-in-class treatment options. MGX-001 is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia A from a single administration.

Metagenomi Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.78
$0.56
-31.09%
Oct 2026
$1.08
$0.82
-23.64%
Sep 2026
$1.18
$1.07
-11.57%
Aug 2026
$1.23
$1.21
+1.68%
Jul 2026
$1.18
$1.19
+0.42%
Jun 2026
$1.33
$1.19
-13.50%
May 2026
$1.34
$1.37
-0.72%
Apr 2026
$1.37
$1.38
+3.76%
Mar 2026
$1.49
$1.33
-13.07%
Feb 2026
$1.52
$1.53
-0.65%
Jan 2026
$1.64
$1.54
-5.23%
Dec 2025
$1.70
$1.63
-7.93%

Metagenomi Share Price FAQs